|
JP2019060872A
|
|
Blood specimen pre-examination treatment method
|
|
JP2019060632A
|
|
Blood specimen pre-examination treatment method
|
|
JP2017106915A
|
|
Method of monitoring t-cell activation from bodily fluid
|
|
JP2017114795A
|
|
Method of predicting effect of combination therapy of l-asparaginase agent and autophagy inhibitor on cancer, and cancer therapy agent
|
|
JP2016075504A
|
|
Management sample of hemoglobin F
|
|
JP2015007622A
|
|
Screening of pcsk9 relative agent or measurement method of pcsk9 to ascertain administration effect of agent
|
|
JP2015006174A
|
|
Standard substance for pcsk9 measurement
|
|
WO2013077332A1
|
|
Method for detecting matrix metalloproteinase-3 by latex agglutination method
|
|
JP2012237752A
|
|
Detection method of hypercholesterolemia and arteriosclerosis
|
|
JP2012145570A
|
|
Method for determining arteriosclerosis by sortilin
|
|
JP2011019512A
|
|
Comparative quantitative method for human papillomavirus
|
|
EP2405275A1
|
|
Method for measuring glycated albumin contained in serum or plasma using mannitol as stabiliser for a control serum or plasma.
|
|
JP2008245641A
|
|
Method for detecting nucleic acid
|
|
WO2007136025A1
|
|
Method of detecting infectious disease
|
|
JP2007244349A
|
|
Method for detecting bacteria of periodontal disease
|
|
JP2007222136A
|
|
Method for detecting periodontal disease bacteria
|
|
JP2007170997A
|
|
Virus-suspension collection method
|
|
JP2007068530A
|
|
Method for detecting sapovirus
|
|
JP2007107950A
|
|
Control sample of glycated albumin
|
|
WO2006033387A1
|
|
Method of detecting gene governing allergic predisposition
|
